New Drop for Dry Eye Approved by FDA

Xiidra from Shire Pharmaceuticals was released this July to treat inflammatory dry eye.  Dry eye disease is a condition that affects 10-15 percent of all Americans.  The optometry community is excited to have another option for it's treatment.  

Xiidra Dry Eye Drops

Xiidra Dry Eye Drops

Read the FDA statement here.  The effectivity of Xiidra was confirmed in a double blind study of thousands of patients ages 19-97 compared against a placebo treatment.

Xiidra is not yet covered by Medicare or other vision and medical insurances.